Oral spherical adsorptive carbon for the treatment of intractable anal fistulas in crohn's disease: A multicenter, randomized, double-blind, placebo-controlled trial

American Journal of Gastroenterology

Volumn 103, Issue 7, 2008, Pages 1721-1729

  Fukuda, Yoshihiro ^a   Takazoe, Masakazu ^b   Sugita, Akira ^c   Kosaka, Tadashi ^a   Kinjo, Fukunori ^d   Otani, Yoshimasa ^e   Fujii, Hisao ^f   Koganei, Kazutaka ^g   Makiyama, Kazuya ^h   Nakamura, Toshio ⁱ   Suda, Takeyasu ^j   Yamamoto, Shojiro ^k   Ashida, Toshifumi ^l   Majima, Akira ^m   Morita, Norikazu ⁿ   Murakami, Kazunari ^o   Oshitani, Nobuhide ^p   Takahama, Kazuya ^q   Tochihara, Masahiro ^r   Tsujikawa, Tomoyuki ^s   Watanabe, Makoto ^q   more..

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Department of Surgery   (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^d UNIVERSITY OF THE RYUKYUS   (Japan)

^e Surgical Department of Kitasato   (Japan)

^f NARA MEDICAL UNIVERSITY   (Japan)

^g YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

^h NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j NIIGATA UNIVERSITY   (Japan)

^k UNIVERSITY OF MIYAZAKI   (Japan)

^l ASAHIKAWA MEDICAL COLLEGE   (Japan)

^m TOKYO MEDICAL UNIVERSITY   (Japan)

ⁿ TAKANO HOSPITAL   (Japan)

^o OITA UNIVERSITY   (Japan)

^p OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^q FUJITA HEALTH UNIVERSITY   (Japan)

^r Sapporo Kosei General Hospital   (Japan)

^s SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AST 120; PLACEBO; CARBON; OXIDE;

ABDOMINAL PAIN; ADULT; ANUS FISTULA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; REMISSION; SIDE EFFECT; VOMITING; ADOLESCENT; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RECTUM FISTULA; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CARBON; CROHN DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDES; RECTAL FISTULA; TREATMENT OUTCOME;

EID: 50649118595     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01860.x     Document Type: Article

References (24)

1. Sugita A, Koganei K, Harada H, et al. Surgery for Crohn's anal fistulas. J Gastroenterol 1995;30(Suppl 8): 143-6.
2. Maeda K, Okada M, Yao T, et al. Intestinal and extrain- testinal complications of Crohn's disease: Predictors and cumulative probability of complications. J Gastroenterol 1994;29:577-82.
3. Schwartz DA, Pemberton JH, Sandborn WJ. Diagnosis and treatment of perianal fistulas in Crohn's disease. Ann Intern Med 2001;135:906-18.
4. Solomon M, McLeod R, O'Connor B, et al. Combination ciprofloxacin and metronidazole in severe pe- rianal Crohn's disease. Can J Gastroenterol 1993;7: 571-3.
5. Sandborn WJ, Present DH, Isaacs KL, et al. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: A randomized, placebo-controlled trial. Gastroenterology 2003;125:380-8.
6. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-405.
7. Sands BE, Anderson FR, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004;350:876-85.
8. Colombel JF, Loftus EV Jr, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients. Gastroenterology 2004;126:19-31.
9. Hirakawa H, Fukuda Y, Tanida N, et al. Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn's disease. Gastroenterol Jpn 1993;28:379-84.
10. Niwa T, Nomura T, Sugiyama S, et al. The protein metabolite hypothesis, a model for the progression of renal failure: An oral adsorbent lowers indoxyl sulfate levels in undia- lyzed uremic patients. Kidney Int Suppl 1997;52:S23-8.
11. Niwa T, Yazawa T, Ise M, et al. Inhibitory effect of oral sor- bent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats. Nephron 1991;57:84-8.
12. Niwa T, Tsukushi S, Ise M, et al. Indoxyl sulfate and progression of renal failure: Effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. Miner Electrolyte Metab 1997;23:179-84.
13. Niwa T, Ise M. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 1994;124:96-104.
14. Sostegni R, Daperno M, Scaglione N, et al. Review article: Crohn's disease: Monitoring disease activity. Aliment Pharmacol Ther 2003;17(Suppl 2):11-7.
15. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976;70: 439-44.
16. The Maintenance and Support Services Organization (MSSO). Medical dictionary for regulatory activities terminology (MedDRA) version 2.4 introductory guide. Reston, VA: MedDRA MSSO, 1999.
17. Present D, Mayer L, VanDeventer SJH, et al. Anti-TNF- alpha chimeric antibody (cA2) is effective in the treatment of the fistulae of Crohn's disease: A multicenter, randomized, double-blind, placebo-controlled study. Am J Gas- troenterol 1997;92:1746.
18. Irvine FJ, FeaganB, Rochon J, etal. Quality of life: Avalid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 1994;106:287-96.
19. Owada A, Nakao M, Koike J, et al. Effect of oral adsorbent AST-120 on the progression of chronic renal failure: A randomized controlled study. Kidney Int Suppl 1997; 52:8188-90.
20. Niwa T, Ise ME, Miyazaki T. Progression of glomeru- lar sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate. Am J Nephrol 1994;14:207-12.
21. Miyazaki T, Ise M, Hirata M, et al. Indoxyl sulfate stimulates renal synthesis of transforming growth factor- beta l and progression of renal failure. Kidney Int Suppl 1997;52:S211 -4.
22. Araki Y, Tsujikawa T, Andoh A, et al. Therapeutic effects of an oral adsorbent on acute dextran sulphate sodium- induced colitis and its recovery phase in rats, especially effects of elimination of bile acids in gut lumen. Dig Liver Dis 2000;32:691-8.
23. Takazoe M, Fukuda Y, Shimoyama T. Treatment of intractable anal fistula related to Crohn's disease with an oral adsorbent (AST-120). Gastroenterology 1997;112: A1102.
24. Tsujikawa T, Araki Y, Makino J, et al. Efficacy of oral adsorbent for treatment of peristomal fistula associated with Crohn's disease. J Gastroenterol 2000;35:296-8.